I’ve had the same conversation more times than I can count. A woman sits across from me, lowers her voice, and says that sex hurts now. Or that she has had her fourth urinary tract infection this year. Or that she stopped wearing certain clothes because everything feels raw.
And almost every time, she has already mentioned it to someone. Her doctor told her to try a lubricant. Another doctor handed her a course of antibiotics and sent her home. Nobody connected the dryness, the pain, and the infections into one picture, because they are one picture.
That picture has a name: genitourinary syndrome of menopause, or GSM. Between 27% and 84% of women past menopause have symptoms, according to the 2025 American Urological Association guideline. That range is huge because so many women never say a word. In this post, I’ll walk you through what is happening in your tissue, what the newest research shows, and why low-dose vaginal estrogen is one of the safest, most underused tools in menopause care.
What Vaginal Dryness Menopause Really Means
Vaginal dryness menopause is not a lubrication problem. It is a tissue problem. And that difference changes everything about how you treat it.
Estrogen keeps the vagina, vulva, urethra, and bladder base thick, stretchy, and well supplied with blood. These tissues carry a dense network of estrogen receptors. So when estrogen falls during perimenopause and menopause, the lining thins. Blood flow drops. The natural folds flatten, and the tissue loses elasticity.
In other words, the skin down there ages in the same way hormone-starved skin anywhere else would, only it takes far more daily wear and sits next to your urinary tract.
The Three Symptoms That Travel Together
GSM shows up in three clusters, and most women have more than one:
- Vaginal symptoms: dryness, burning, itching, and a feeling of pressure or rawness.
- Sexual symptoms: pain with penetration (called dyspareunia), tearing, light bleeding after sex, and less arousal because touch hurts.
- Urinary symptoms: urgency, burning, needing to go often, and repeat UTIs.
Here’s what that means: if you have two of those three, your doctor should be thinking about hormone-depleted tissue, not just bacteria or bad luck.
Why Hot Flashes Fade but This Does Not
Hot flash symptoms usually ease with time. GSM does the opposite. Because the tissue stays estrogen-starved, symptoms tend to hold steady or worsen year after year. That’s one reason I tell women in my practice that waiting it out is not a plan.
Why Painful Sex After Menopause Is Not in Your Head
Painful sex is the symptom women are most embarrassed to bring up. It’s also the one that can quietly strain a marriage or end intimacy altogether.
I see this in my practice constantly. A woman assumes her desire vanished. In fact, her desire is intact, but her body now sends a pain signal every time she tries. So she avoids touch. Her partner reads the avoidance as rejection. Neither one says anything.
The mechanism is physical. A thin, dry lining tears more easily under friction. The pelvic floor muscles tighten in anticipation of pain, which makes penetration hurt more. Pain then trains the muscles to brace harder next time.
Lubricants help with vaginal dryness menopause during sex, and I never discourage them. But a lubricant works for minutes. It does not rebuild tissue. Think of it as a raincoat on a house with a leaking roof.
Why You Keep Getting UTIs After Menopause
Now for the part conventional medicine misses most often. The same thinning that causes dryness also changes the urinary tract’s defenses.
Estrogen feeds protective bacteria called lactobacilli. These bacteria make lactic acid and keep vaginal pH low, around 4 to 4.5. When estrogen drops, lactobacilli decline. The pH climbs, and gut bacteria such as E. coli move in more easily. The urethra, which shortens and thins without estrogen, gives them a shorter path to the bladder.
So the infection is not a hygiene failure. You did not do something wrong.
Still, the usual script is antibiotics, then more antibiotics, then a low-dose antibiotic taken for months. Each round treats the infection and leaves the cause alone. Women come to me exhausted by this loop, and some have also developed antibiotic-resistant infections along the way. Nobody is asking why the tissue became so easy to infect.
What the 2024 Randomized Trial Found
Let’s look at the evidence. A 2024 randomized, double-blind trial in the journal Maturitas tested an ultra-low-dose vaginal estriol gel in women past menopause with GSM. The team ran it at 28 sites in Spain.
How the Study Worked
Researchers enrolled 115 women for the safety analysis. A total of 108 women completed the efficacy analysis: 53 used the estriol gel and 55 used a placebo gel. The estriol gel contained just 50 micrograms of estriol (0.005%). Women applied 1 gram daily for 3 weeks, then twice weekly through week 24.
The placebo was not a sham. It was an identical moisturizing gel without estrogen. That detail matters, because it means the estrogen group beat a real moisturizer.
What They Found
Here’s what they found:
- UTI rate with estriol: 32.34 cases per 100 person-years.
- UTI rate with placebo: 43.76 cases per 100 person-years.
- That works out to a 26% lower infection rate (incidence rate ratio 0.74, p < 0.001).
- Vaginal pH fell 7.28% by week 3 and 8.42% by week 24 in the estriol group.
- Among estriol users, 86.8% had zero UTIs during treatment, and the remaining 13.2% had only one.
Translation: a tiny dose of estrogen, applied twice a week after the first three weeks, cut infections and moved vaginal pH back in the right direction. And it did so against a moisturizing gel, not against nothing.
Safety and Tolerability in the Same Trial
Safety looked reassuring. Product-related side effects hit 17.5% of women on estriol and 27.6% on placebo. Two estriol users dropped out because of side effects, compared with six on placebo. And 90.9% of women rated the treatment as excellent or very good.
I want to be honest about the limits. This trial ran for 24 weeks, so it cannot tell us about decade-long use. It also did not measure endometrial thickness itself, so it leaned on earlier data for that question. That said, it fits a pattern that guideline panels have now reviewed in much larger bodies of evidence.
What the AUA Guideline Says About Vaginal Estrogen
In 2025, the American Urological Association, the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, and the American Urogynecologic Society released the first joint guideline on GSM. Its key statements line up closely with what I do in my practice:
- Dryness and painful sex: doctors should offer local low-dose vaginal estrogen. This is a strong recommendation.
- Recurrent UTIs: doctors should recommend local low-dose vaginal estrogen to cut the risk of future infections. This carries a moderate recommendation backed by Grade B evidence, the strongest grade in the guideline.
- Women already on systemic hormone therapy: doctors may still add local vaginal estrogen.
- Breast cancer history: the guideline found no evidence linking local low-dose vaginal estrogen to breast cancer development.
- The uterus: it states that local vaginal estrogen does not raise the risk of endometrial hyperplasia with atypia or endometrial cancer.
Read that list again. A urology and urogynecology guideline says to recommend this treatment for repeat UTIs. Yet most women with recurrent infections never hear the word “estrogen” at all.
Is Low-Dose Vaginal Estrogen Safe?
This is the question I hear most, and I understand why. Many women remember the headlines from the early 2000s about hormone therapy and breast cancer. Those headlines came from studies of high-dose oral estrogen, usually paired with a synthetic progestin. Labels on some vaginal products still carry warnings that grew out of that research.
But vaginal estrogen is not the same drug at the same dose. It acts locally. Standard products deliver a very small amount, such as a 10 microgram estradiol insert, and blood levels of estrogen generally stay in the range typical after menopause. Medicine applied the oral hormone findings broadly to every form of estrogen, and I’ve never been satisfied with that shortcut.
What I Tell Women in My Practice
Most healthy women past menopause can use low-dose vaginal estrogen safely, and many can use it for years. If you have a history of breast cancer, I do not wave away your concern. Instead, the AUA guideline says to make this call through shared decision-making with your oncology team. In fact, some women with breast cancer history suffer such severe GSM that treatment makes a real difference in their lives.
And if you have unexplained vaginal bleeding after menopause, get it checked first. That rule holds whether or not you use any hormone.
Your Treatment Options, From Gentle to Targeted
Women ask me which product is best. The honest answer is that the best one is the one you will use consistently. Here are the main choices:
- Vaginal estradiol inserts: a small tablet or softgel placed in the vagina, often daily for two weeks and then twice weekly.
- Vaginal estrogen cream: more flexible dosing, and some women like using it on the vulva and near the urethra.
- Estrogen ring: a soft ring that sits in the vagina and releases a steady low dose, changed about every 90 days.
- Estriol gel or cream: the weaker estrogen studied in the Maturitas trial, available through some compounding and international channels.
- Vaginal DHEA (prasterone): a nightly insert that turns into estrogen and testosterone inside local cells.
- Oral ospemifene: a pill that acts like estrogen on vaginal tissue, for women who prefer not to use anything vaginal.
Additionally, a few non-hormone tools help at the edges. Vaginal moisturizers, used two to three times a week, hydrate the surface. Water-based or silicone lubricants reduce friction during sex. Pelvic floor physical therapy loosens muscles that learned to brace against pain.
So no, I’m not saying everyone must use estrogen. I’m saying you deserve to hear that it exists, that the data supports it, and that you can weigh it against the alternatives with a doctor who listens.
What a Functional Medicine Approach Adds
Local treatment is the foundation for vaginal dryness menopause care. But I look at the whole picture, because GSM rarely travels alone.
Specifically, I check whether you also have hot flash symptoms, poor sleep, or mood changes that suggest low systemic estrogen. I look at your testosterone and thyroid, since both affect tissue health and desire. I review your medications, because antihistamines, some antidepressants, and certain blood pressure drugs dry mucous membranes. And I ask about your gut and your urine history, because a pattern of infections deserves a proper workup instead of a sixth prescription.
What This Looks Like in Practice
Picture a woman I’ll call Carol, a composite of several patients. She is 61, and she had four UTIs in 12 months. She had stopped having sex because it hurt, and she had begun to feel like a stranger in her own body. Her doctors treated each infection separately.
At her visit, we connected the pieces. We started a low-dose vaginal estradiol insert, added a moisturizer, and referred her to a pelvic floor therapist. Within a few months, the burning eased. The infections stopped coming back as often. And she told me the most important change was that she no longer dreaded intimacy.
Carol’s story is illustrative, not a promise. But I’ve watched some version of it unfold many times.
When to See Someone About This
Please do not wait if any of these sound familiar:
- Sex hurts or tears, or you bleed afterward.
- You have had two UTIs in six months, or three in one year.
- Burning or itching lasts more than a few weeks.
- Lubricants and moisturizers no longer help.
- You avoid exercise, travel, or intimacy because of discomfort.
A good workup includes a pelvic exam, a urine culture when you have symptoms, and a thorough conversation about your history. If your doctor shrugs this off, find a doctor who does not.
Key Takeaways
- GSM affects 27% to 84% of women past menopause, and it usually gets worse without treatment, not better.
- Dryness, painful sex, and repeat UTIs often share one cause: thin, estrogen-starved tissue.
- A 2024 randomized trial of 108 women found 26% fewer UTIs with ultra-low-dose vaginal estriol than with a placebo gel.
- The 2025 AUA guideline recommends low-dose vaginal estrogen for dryness, painful sex, and recurrent UTIs, and found no link to breast cancer or endometrial cancer.
- Lubricants help during sex, but they do not repair tissue, so ask your doctor about local estrogen and pelvic floor therapy.
Frequently Asked Questions
Is vaginal dryness menopause treatable, or do I just have to live with it? It is treatable. Local low-dose vaginal estrogen is the first-line medical treatment, and moisturizers, lubricants, and pelvic floor therapy add to it. In fact, most women notice some relief within a few weeks, though full tissue repair can take 8 to 12 weeks. So give a treatment a fair trial before judging it.
Why does sex hurt more after menopause even though I still want it? Because falling estrogen thins and dries the vaginal lining, and pelvic muscles tighten in response to pain. Desire and comfort are separate things. As a result, your interest can stay strong while your body signals pain, and treating the tissue usually fixes the pain first.
Safety Questions About Vaginal Estrogen
Does low-dose vaginal estrogen raise breast cancer risk? The 2025 AUA guideline found no evidence linking local low-dose vaginal estrogen to breast cancer development. Systemic hormone therapy is a different question. If you have a breast cancer history, the guideline says doctors may recommend it after shared decision-making with your oncology team.
Do I need a progestin if I use vaginal estrogen and still have my uterus? Generally not for standard low-dose products. The AUA guideline states that local low-dose vaginal estrogen does not increase the risk of endometrial hyperplasia with atypia or endometrial cancer. That said, report any bleeding after menopause so your doctor can check it.
Practical Questions About Treatment
How long do I need to use it? GSM is chronic, so symptoms usually return when you stop. Most women stay on a low maintenance dose, often twice a week. Your doctor should review it with you at least once a year.
Can vaginal estrogen really prevent UTIs? Yes. In the 2024 Maturitas trial, infections fell 26% in the estriol group, and the AUA gives this a Grade B rating. It will not stop every infection. But it fixes a root cause that antibiotics leave untouched.
Dr. Betty’s Bottom Line
Vaginal dryness menopause is not a character flaw, and it is not something you must tolerate quietly. It is a predictable result of estrogen loss in tissue that depends on estrogen to stay healthy.
The evidence now backs what I have seen for years. A 2024 trial found 26% fewer UTIs with a tiny estriol dose, and the AUA guideline says doctors should recommend local vaginal estrogen for recurrent infections. Meanwhile, the guideline found no link to breast cancer or endometrial cancer.
Women deserve the full menu: local estrogen, non-hormone options, and pelvic floor care. And you deserve a doctor who asks about these symptoms before you have to whisper them. If you have been told to live with it, I’m telling you that you don’t have to.
In-person care at Living Well Dallas Functional Medicine Center is available for patients in the Dallas area, with visits that cover your symptoms, hormone levels, urinary history, medications, and a personalized plan for vaginal and urinary health.
Source: Muiños Fernández N, Martínez Salamanca JI, et al. Efficacy and safety of an ultra-low-dose 0.005% estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: a randomized, double-blind, placebo-controlled trial. Maturitas. 2024;190:108128. https://doi.org/10.1016/j.maturitas.2024.108128. Guideline: American Urological Association, SUFU, and AUGS. Genitourinary Syndrome of Menopause Guideline. 2025. https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopause